Jonathan Perkins, D.O.
Jonathan A. Perkins, D.O., is a professor of pediatric otolaryngology-head and neck surgery at the University of Washington and is chief of the Vascular Anomalies program at Seattle Children's Hospital. Perkins earned his D.O. at the University of Osteopathic Medicine and Health Sciences, did his residency training in otolaryngology at Madigan Army Medical Center in Fort Lewis, WA, and a pediatrics fellowship at Seattle Children's Hospital and the University of Washington.
While practicing all aspects of pediatric otolaryngology, his primary research interests are communication disorders and vascular anomalies of the head and neck. He serves as head of the Vascular Anomalies multidisciplinary service which is now the largest such service in the western United States. He also participates in the Craniofacial Center with a focus on palate repair. He practices at both the Bellevue and Sand Point campuses.
Undergraduate Education: Biola College, La Mirada, Cal., and University of Washington
Medical School: University of Osteopathic Medicine and Health Sciences, Des Moines, Iowa
Internship: Madigan Army Medical Center, Tacoma, Wash.
Residency: Surgery - General, Madigan Army Medical Center - Credentialing Office, Tacoma, Wash.
Fellowship: Pediatric Otolaryngology/Head and Neck Surgery Seattle Children's Hospital, Seattle, Wash.
Board Certification: Otolaryngology
Memberships: American Academy of Otolaryngology- Head and Neck Surgery, American Academy of Facial Plastic and Reconstructive Surgery
Awards and honors
2015, 2009: Trachy Faculty Research Award, UW Otolaryngology-HNS
2015: Robert Ruben Award for Scientific Achievement, SENTAC
2013: Charles Ferguson Award
2012: Washington Top Doctors
2009: Elsevier Publishing/Am Acad of Oto/HNS Foundation Travel Award
2007-present: Best Doctors of America
Certificate of Honor, American Academy Oto/HNS
Head and neck surgery, cleft palate treatment, velopharyngeal insufficiency, vascular birthmark treatment (lymphatic malformation, hemangioma, arteriovenous malformation), vascular/lymphatic endothelium research
Translational research and vascular anomalies
Li D, March ME, Gutierrez-Uzquiza A, Kao C, Seiler C, Pinto E, Matsuoka LS, Battig MR, Bhoj EJ, Wenger TL, Tian L, Robinson N, Wang T, Liu Y, Weinstein BM, Swift M, Jung HM, Kaminski CN, Chiavacci R, Perkins JA, Levine MA, Sleiman PMA, Hicks PJ, Strausbaugh JT, Belasco JB, Dori Y, Hakonarson H. ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor., Nat. Med. 2019 07; 25(7):1116-1122
Zenner K, Dahl J, Deutsch G, Rudzinski E, Bly R, Perkins JA. Metastatic cellular neurothekeoma in childhood., Int. J. Pediatr. Otorhinolaryngol. 2019 04; 11986-88
Chewning RH, Monroe EJ, Lindberg A, Koo KSH, Ghodke BV, Gow KW, Javid PJ, Jinguji TM, Perkins JA, Shivaram GM. Combined glue embolization and excision for the treatment of venous malformations., CVIR Endovasc 2018 ; 1(1):22
Strub GM, Perkins JA. MicroRNAs for the pediatric otolaryngologist., Int. J. Pediatr. Otorhinolaryngol. 2018 Sep; 112195-207
Lab contact info